Editorial  by unknown
In the recent progress of medicine and healthcare, biomarker and genomic medicine play 
signiﬁcant roles, especially in the personalized medicine. In order to specify the scope and 
strengthen the impressions on the journal, Genomic Medicine, Biomarkers, and Health 
Sciences (GMBHS) officially changes the title to Biomarkers and Genomic Medicine (BGM) 
since 2013.
Under the new title, we greatly welcome the papers of distinctive research on both basic 
medical science and translational application in the ﬁelds of genomic medicine, biomarkers, 
cell signaling, biotechnology, pharmacogenomics and health sciences. Except the modiﬁed 
ﬁelds of interest, all the categories of articles and the editorial process remain the same as 
GMBHS. The BGM is still the official peer-reviewed publication of Taiwan Genomic Medicine 
and Biomarker Society, supported by Fooyin University Hospital and published quarterly by 
Elsevier. 
We appreciate the long-term supports and contributions from all the readers, authors, editors 
and reviewers. On the achievement made by GMBHS, we will continue being devoted to make 
the BGM a high-quality journal publishing superior scholarly articles and sharing the latest 
information on the research and development of biomarkers and genomic medicine.
The alteration, the specialization
